A highly sensitive bone marrow test could double survival rates for some groups of younger adults with Acute Myeloid Leukemia ...

AML patients in the trial who were treated with SENTI-202 experienced complete remission after not responding to prior ...

Researchers have developed a new gene expression atlas to map how abnormal differentiation of hematopoietic cells can lead to acute myeloid leukemia (AML).

From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ...

A highly sensitive bone marrow test could double survival rates for some groups of younger adults with acute myeloid leukemia ...

For months, college student Breeze Hunter, 22, felt pressure and pain in her head. “I had a lot of fluid in my ears, which ...

A new single-cell reference atlas of normal hematopoiesis has helped researchers identify novel acute myeloid leukemia cell ...

May Overcome Resistance to Azacitidine-Venetoclax Regimen and Trigger Apoptosis of TP53 Mutated AML CellsNEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) ...

A novel drug combination targeting LSD1 and GSK3 shows promise in treating acute myeloid leukemia by promoting cell ...

A ready-made version of a cutting-edge cancer immunotherapy can effectively defeat blood cancers, a new study says.

The new treatment, which uses a type of immune cell called natural killer cells, promoted complete remission in several ...